Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 2.09 USD -0.33% Market Closed
Market Cap: 4.8m USD

Wall Street
Price Targets

RDHL Price Targets Summary
Redhill Biopharma Ltd

There are no price targets for RDHL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Redhill Biopharma Ltd Competitors:
Price Targets
KOTRA
Kotra Industries Bhd
20% Upside
HIKAL
Hikal Ltd
49% Upside
4015
Jamjoom Pharmaceuticals Factory Company SJSC
16% Upside
VRNA
Verona Pharma PLC
6% Downside
CONCORDBIO
Concord Biotech Ltd
6% Upside

Revenue
Forecast

Revenue Estimate
Redhill Biopharma Ltd

For the last 11 years the compound annual growth rate for Redhill Biopharma Ltd's revenue is 84%. The projected CAGR for the next 1 year is 382%.

84%
Past Growth
382%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Redhill Biopharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Redhill Biopharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RDHL's stock price target?
Not Available

RDHL doesn't have any price targets made by Wall Street professionals.

What is Redhill Biopharma Ltd's Revenue forecast?
Projected CAGR
382%

For the last 11 years the compound annual growth rate for Redhill Biopharma Ltd's revenue is 84%. The projected CAGR for the next 1 year is 382%.

Back to Top